Reason for request
Assessment of the dosage change permitting use in children.
Clinical Benefit
| Substantial |
The actual benefit of this medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
The medicinal product SMOFLIPID has the same actual benefit in the paediatric population as previously recognised by the transparency Committee in adults (IAB V). |
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
r4ybBubkFyCcmynV
